BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19795479)

  • 1. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.
    Zhou Q; Armstrong B; Larson I; Stewart PJ; Morton DA
    J Pharm Sci; 2010 Feb; 99(2):969-81. PubMed ID: 19795479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials.
    Faqih AM; Mehrotra A; Hammond SV; Muzzio FJ
    Int J Pharm; 2007 May; 336(2):338-45. PubMed ID: 17289312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Coating Materials and Processing Conditions on Flow Enhancement of Cohesive Acetaminophen Powders by High-Shear Processing With Pharmaceutical Lubricants.
    Wei G; Mangal S; Denman J; Gengenbach T; Lee Bonar K; Khan RI; Qu L; Li T; Zhou QT
    J Pharm Sci; 2017 Oct; 106(10):3022-3032. PubMed ID: 28551425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties.
    Zhou QT; Qu L; Gengenbach T; Denman JA; Larson I; Stewart PJ; Morton DA
    Int J Pharm; 2011 Jul; 413(1-2):36-43. PubMed ID: 21527321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of coating material on the flowability and dissolution of dry-coated fine ibuprofen powders.
    Qu L; Zhou QT; Denman JA; Stewart PJ; Hapgood KP; Morton DA
    Eur J Pharm Sci; 2015 Oct; 78():264-72. PubMed ID: 26215464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-step Coprocessing of Cohesive Powder via Mechanical Dry Coating for Direct Tablet Compression.
    Qu L; Stewart PJ; Hapgood KP; Lakio S; Morton DAV; Zhou QT
    J Pharm Sci; 2017 Jan; 106(1):159-167. PubMed ID: 27665128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach.
    Zhou QT; Qu L; Larson I; Stewart PJ; Morton DA
    Int J Pharm; 2010 Jul; 394(1-2):50-9. PubMed ID: 20435112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry Powder Coating using Planetary Centrifugal Mixer.
    Miyazaki Y; Miyawaki K; Uchino T; Kagawa Y
    J Pharm Pharm Sci; 2015; 18(3):460-73. PubMed ID: 26517137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the physical properties of dry surface-modified ibuprofen using a powder rheometer (FT4) and analysis of the influence of pharmaceutical additives on improvement of the powder flowability.
    Ono T; Yonemochi E
    Int J Pharm; 2020 Apr; 579():119165. PubMed ID: 32081804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach.
    Zhou QT; Denman JA; Gengenbach T; Das S; Qu L; Zhang H; Larson I; Stewart PJ; Morton DAV
    J Pharm Sci; 2011 Aug; 100(8):3421-3430. PubMed ID: 21455980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mechanical dry coating with magnesium stearate on flowability and compactibility of plastically deforming microcrystalline cellulose powders.
    Koskela J; Morton DAV; Stewart PJ; Juppo AM; Lakio S
    Int J Pharm; 2018 Feb; 537(1-2):64-72. PubMed ID: 29198809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP; Elliott JA; Cameron RE
    Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations.
    Guchardi R; Frei M; John E; Kaerger JS
    Int J Pharm; 2008 Feb; 348(1-2):10-7. PubMed ID: 17689898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.